Description
JUPIZOMIB-2
A major break through in the treatment of multiple myeloma
JUPIZOMIB-2
JUPIZOMIB-2
Bortezomib 2mg Injection
A major break through in the treatment of multiple myeloma. First-in-class reversible and selective proteasome inhibitor
Related products
-
JUPITAXEL-20
JUPITAXEL-20 Docetaxel 20mg Injection For the management of multiple metastatic and non-resectable …Read more -
JUPITINIB-400
JUPITINIB-400 Imatinib 400mg Tablets Induces apoptosis of leukemic cells. Known as “Magical Bullet,” …Read more -
JUPIPAC-100
JUPIPAC-100 Paclitaxel 100 mg Injection The first microtubule targeting agent Broad activity in …Read more
